A Study to Evaluate the Effects of the Combination of GI-102 With GIB-7 on Biomarkers of Aging in Healthy Adults and Cancer Survivors

This study is testing whether a combination of two supplements — GI-102 and GIB-7 — can positively affect biological markers associated with aging in healthy adults and cancer survivors. The goal is to understand if these supplements may support healthier aging at a cellular level. **You may be eligible if...** - You are between 18 and 80 years old - You are in generally good health without a life-threatening illness - If you have had cancer, you have been disease-free for at least 2 years, OR you have been in remission for at least 12 months and are not currently on active cancer treatment (maintenance therapy like hormone therapy is okay) **You may NOT be eligible if...** - You are currently undergoing active cancer treatment (other than maintenance therapy) - You have a serious ongoing illness or disability - You do not meet the study's health thresholds as assessed by the study team Talk to your doctor to see if this trial is right for you.